Get started today

Safety of Medicinal Cannabis

Presented by Associate Professor Ali Seyfoddin.

About this module:

In this presentation, Associate Professor Ali Seyfoddin gives a summary of the safety aspects of cannabis, tetrahydrocannabinol (THC) and cannabidiol (CBD) including common side effects, drug-cannabis interactions, and contraindications. He also explores some of the scientific evidence of safety of cannabis in the treatment of specific illnesses, as well as safety in relation to long-term use. 

This presentation is suitable for healthcare practitioners and those with a background in biomedical sciences. It assumes a knowledge of the endocannabinoid system and medicinal cannabis pharmacodynamics.
Learning Outcomes

At the end of this module, learners will be able to:

  • Describe the potential side effects of cannabis (and tetrahydrocannabinol).
  • Describe the potential side effects of cannabidiol (CBD).
  • Assess the potential for interactions between medicinal cannabis products and pharmaceuticals.
  • Discuss potential contraindications for the use of medicinal cannabis.
  • Debate the level of scientific evidence of safety of cannabis for a range of clinical conditions.

Assoc Prof. Ali Seyfoddin

Dr Ali Seyfoddin is the Deputy Head of School of Science at Auckland University of Technology. Trained as a pharmacist, he leads the Drug Delivery Research Group ( and his research interests are primarily pharmaceutical formulation, biological engineering and bioprospecting.

Being practically minded, he finds application for his research in natural drug discovery, nanoencapsulation, 3D- and bio-printing, aquaculture feed technology and medicinal cannabis (cultivation, processing, extraction and formulation). He also teaches a range of undergraduate and postgraduate courses related to pharmacology, biomedical sciences and medicinal cannabis science.
Created with